Cargando…
PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease
The peroxisome proliferator-activated receptors (PPARs) consist of three related transcription factors that serve to regulate a number of cellular processes that are central to cardiovascular health and disease. Numerous pharmacologic studies have assessed the effects of specific PPAR agonists in cl...
Autor principal: | Cresci, Sharon |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2288645/ https://www.ncbi.nlm.nih.gov/pubmed/18401448 http://dx.doi.org/10.1155/2008/374549 |
Ejemplares similares
-
Therapeutic Implications of PPARγ in Cardiovascular Diseases
por: Hasegawa, Hiroshi, et al.
Publicado: (2010) -
Pharmacogenomics and migraine: possible implications
por: Tfelt-Hansen, Peer, et al.
Publicado: (2008) -
Use of pharmacogenomics in elderly patients treated for cardiovascular diseases
por: Božina, Nada, et al.
Publicado: (2020) -
Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa
por: Baker, J L, et al.
Publicado: (2017) -
Pharmacogenomics and Opioid Analgesics: Clinical Implications
por: Yiannakopoulou, Eugenia
Publicado: (2015)